These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 616121)
21. An automated method for the assessment of spontaneous and stereotyped climbing behavior in mice. Effects of the selective D1- and D2-dopamine receptor agonists SKF-38393 and RU-24926 and their association. Simon P; Charpentier S; Costentin J Methods Find Exp Clin Pharmacol; 1991 Mar; 13(2):99-104. PubMed ID: 1830125 [TBL] [Abstract][Full Text] [Related]
22. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity. De Veaugh-Geiss J; Devanand DP; Carey RJ Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268 [TBL] [Abstract][Full Text] [Related]
23. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease. Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870 [TBL] [Abstract][Full Text] [Related]
24. Lidocaine kindling is accompanied by an increase in apomorphine stereotypy and mesolimbic dopamine D2 receptor density. Csernansky JG; Csernansky CA; Glick SA; Hollister LE Psychopharmacol Bull; 1985; 21(3):707-11. PubMed ID: 2930865 [No Abstract] [Full Text] [Related]
29. Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist. Pawłowski L; Siwanowicz J; Bigajska K; Przegaliński E Pol J Pharmacol Pharm; 1985; 37(2):179-96. PubMed ID: 4048012 [TBL] [Abstract][Full Text] [Related]
30. Reinstatement of eating by dopamine agonists in aphagic dopamine denervated rats. Ljungberg T; Ungerstedt U Physiol Behav; 1976 Mar; 16(3):277-83. PubMed ID: 1033572 [No Abstract] [Full Text] [Related]
31. Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists. Kondo T J Neurol; 2002 Sep; 249 Suppl 2():II25-9. PubMed ID: 12375060 [TBL] [Abstract][Full Text] [Related]
32. Motor response to a dopamine D3 receptor preferring agonist compared to apomorphine in levodopa-primed 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys. Blanchet PJ; Konitsiotis S; Chase TN J Pharmacol Exp Ther; 1997 Nov; 283(2):794-9. PubMed ID: 9353400 [TBL] [Abstract][Full Text] [Related]
33. Choline chloride in animal models of tardive dyskinesia. Davis KL; Hollister LE; Vento AL; Simonton S Life Sci; 1978 May; 22(19):1699-707. PubMed ID: 566830 [No Abstract] [Full Text] [Related]
34. Effects of dopamine agonists in tardive dyskinesia. Smith RC; Tamminga CA; Haraszti J; Pandey GN; Davis JM Am J Psychiatry; 1977 Jul; 134(7):763-8. PubMed ID: 869053 [TBL] [Abstract][Full Text] [Related]
35. Animal models of tardive dyskinesia: their use in the search for new treatment methods. Goetz CG; Klawans HL; Carvey P Mod Probl Pharmacopsychiatry; 1983; 21():5-20. PubMed ID: 6140633 [No Abstract] [Full Text] [Related]
36. Postsynaptic supersensitivity and kindling: further evidence of similarities. Flemenbaum A Am J Drug Alcohol Abuse; 1978; 5(2):247-54. PubMed ID: 570804 [TBL] [Abstract][Full Text] [Related]
37. Experimental torticollis in the monkey produced by unilateral 6-hydroxy-dopamine brain lesions. Crossman AR; Sambrook MA Brain Res; 1978 Jun; 149(2):498-502. PubMed ID: 96912 [No Abstract] [Full Text] [Related]
38. The effect of chronic levodopa on haloperidol induced behavioral supersensitivity in the guinea pig. Weiner WJ; Carvey P; Nausieda PA; Goetz CG; Klawans HL Life Sci; 1981 May; 28(19):2173-8. PubMed ID: 7195969 [No Abstract] [Full Text] [Related]